Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.3601
-0.0398 (-9.95%)
At close: Apr 28, 2026, 4:00 PM EDT
0.3707
+0.0106 (2.94%)
After-hours: Apr 28, 2026, 7:16 PM EDT
Mangoceuticals Employees
Mangoceuticals had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$152,007
Profits / Employee
-$7,272,998
Market Cap
6.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | - | - |
| Sep 30, 2022 | 2 | - | - |
| Jun 30, 2022 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| American Well | 562 |
| DarioHealth | 165 |
| VSee Health | 154 |
| Mobile-health Network Solutions | 89 |
| Healthcare Triangle | 59 |
| Forian | 50 |
| Zhongchao | 33 |
| OneMedNet | 23 |
MGRX News
- 5 weeks ago - Mangoceuticals Stock Doubles After Texas Lawsuit - Benzinga
- 6 weeks ago - Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. - GlobeNewsWire
- 7 weeks ago - Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds - GlobeNewsWire
- 2 months ago - Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study - GlobeNewsWire
- 2 months ago - Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally? - Benzinga
- 2 months ago - Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model - Benzinga
- 2 months ago - MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program - GlobeNewsWire
- 4 months ago - Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements - GlobeNewsWire